GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BA058 | Tymlos®
abaloparatide is an approved drug (FDA (2017))
Compound class:
Peptide
Comment: Abaloparatide is a synthetic analogue of the 34 amino-terminal residues of human parathyroid hormone-related protein (PTHrP) [1]. Compare this to the approved drug teriparatide which is a synthetic analogue of human parathyroid hormone (PTH). Abaloparatide and teriparatide are synthetic peptides that help grow and strengthen bone.
|
Classification ![]() |
|
| Compound class | Peptide |
| Approved drug? | Yes. US FDA (2017) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9794 | abaloparatide |
Synonyms ![]() |
| BA058 | Tymlos® |
Database Links ![]() |
|
| Specialist databases | |
| GPCRdb Ligand | abaloparatide |
| Other databases | |
| GtoPdb PubChem SID | 252166511 |
| Search PubMed clinical trials | abaloparatide |
| Search PubMed titles | abaloparatide |
| Search PubMed titles/abstracts | abaloparatide |
| Wikipedia | BA058 |